Donald L. Trump, MD, FACP
Dr. Donald Trump discusses why some clinicians use a surveillance approach in the treatment of certain prostate cancers. He addresses criteria in taking this approach, including cancer biopsy results, appearance under the microscope, and Gleason grade.
Dr. Donald Trump addresses a few situations where there is good evidence that a reduction in male hormone levels can be achieved by anti-androgen treatment or androgen deprivation treatments. He discusses instances when the use of androgen deprivation or hormone therapy in combination with radiation in properly selected circumstances yields a superior outcome.
Dr. Donald Trump discusses alternate treatment options for prostate cancer patients once hormone therapy stops working. He addresses the various types of therapies and treatments that can improve the quality and length of survival in men whose prostate cancer has become active again.
Dr. Donald Trump discusses the role of chemotherapy in the treatment of prostate cancer patients. He addresses FDA-approved drugs which will improve quality of survival in men with prostate cancer who are no longer being helped with hormone therapy.
Dr. Donald Trump discusses a new prostate cancer vaccine and its results in the treatment of men with prostate cancer. He addresses how studies indicate that the vaccine has resulted in improved overall survival rates in men with prostate cancer.